Payne AH, O'Shaughnessy P (1996). "Structure, function, and regulation of steroidogenic enzymes in the Leydig cell". En Payne AH, Hardy MP, Russell LD. Leydig Cell. Cache River Press - Vienna [Il]. pp. 260–285. ISBN0-9627422-7-9.
Cox RM, John-Alder HB (2005). "Testosterone has opposite effects on male growth in lizards (Sceloporus spp.) with opposite patterns of sexual size dimorphism". J. Exp. Biol.208 (Pt 24): 4679–87. PMID16326949. doi:10.1242/jeb.01948.
Mooradian AD, Morley JE, Korenman SG (1987). "Biological actions of androgens". Endocr. Rev.8 (1): 1–28. PMID3549275. doi:10.1210/edrv-8-1-1.
Tuck SP, Francis RM (2009). "Testosterone, bone and osteoporosis". Front Horm Res37: 123–32. PMID19011293. doi:10.1159/000176049.
De Loof, Arnold (2006). "Ecdysteroids: the overlooked sex steroids of insects? Males: the black box". Insect Science13 (5): 325–338. doi:10.1111/j.1744-7917.2006.00101.x.
Mechoulam R, Brueggemeier RW, Denlinger DL (1984). "Estrogens in insects". Journal Cellular and Molecular Life Sciences40 (9): 942–944. doi:10.1007/BF01946450.
Waterman MR, Keeney DS (1992). "Genes involved in androgen biosynthesis and the male phenotype". Horm. Res.38 (5-6): 217–21. PMID1307739. doi:10.1159/000182546.
Swerdloff RS, Wang C, Bhasin S (1992). "Developments in the control of testicular function". Baillieres Clin. Endocrinol. Metab.6 (2): 451–83. PMID1377467. doi:10.1016/S0950-351X(05)80158-2.
Mehta PH, Josephs RA (2006). "Testosterone change after losing predicts the decision to compete again". Horm Behav50 (5): 684–92. PMID16928375. doi:10.1016/j.yhbeh.2006.07.001.
Schultheiss OC, Campbell KL, McClelland DC (1999). "Implicit power motivation moderates men's testosterone responses to imagined and real dominance success". Horm Behav36 (3): 234–41. PMID10603287. doi:10.1006/hbeh.1999.1542.
Liu PY, Pincus SM, Takahashi PY, Roebuck PD, Iranmanesh A, Keenan DM, Veldhuis JD (2006). "Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade". Am. J. Physiol. Endocrinol. Metab.290 (1): E34–E41. PMID16339924. doi:10.1152/ajpendo.00227.2005.
Hulmi JJ, Ahtiainen JP, Selänne H, Volek JS, Häkkinen K, Kovanen V, Mero AA (2008). "Androgen receptors and testosterone in men--effects of protein ingestion, resistance exercise and fiber type". J. Steroid Biochem. Mol. Biol.110 (1-2): 130–7. PMID18455389. doi:10.1016/j.jsbmb.2008.03.030.
Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ (1996). "Zinc status and serum testosterone levels of healthy adults". Nutrition12 (5): 344–8. PMID8875519. doi:10.1016/S0899-9007(96)80058-X.
Koehler K, Parr MK, Geyer H, Mester J, Schänzer W (2009). "Serum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement". Eur J Clin Nutr63 (1): 65–70. PMID17882141. doi:10.1038/sj.ejcn.1602899.
Josephs RA, Guinn JS, Harper ML, Askari F (2001). "Liquorice consumption and salivary testosterone concentrations". Lancet358 (9293): 1613–4. PMID11716893. doi:10.1016/S0140-6736(01)06664-8.
Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş N (2007). "Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism". Phytother Res21 (5): 444–7. PMID17310494. doi:10.1002/ptr.2074.
Kumar V, Kural MR, Pereira BM, Roy P (2008). "Spearmint induced hypothalamic oxidative stress and testicular anti-androgenicity in male rats - altered levels of gene expression, enzymes and hormones". Food Chem. Toxicol.46 (12): 3563–70. PMID18804513. doi:10.1016/j.fct.2008.08.027.
Grant P (2010). "Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial". Phytother Res24 (2): 186–8. PMID19585478. doi:10.1002/ptr.2900.
Meinhardt U, Mullis PE (2002). "The essential role of the aromatase/p450arom". Semin. Reprod. Med.20 (3): 277–84. PMID12428207. doi:10.1055/s-2002-35374.
Breiner M, Romalo G, Schweikert HU (1986). "Inhibition of androgen receptor binding by natural and synthetic steroids in cultured human genital skin fibroblasts". Klin. Wochenschr.64 (16): 732–7. PMID3762019. doi:10.1007/BF01734339.
Forest MG, Cathiard AM, Bertrand JA (1973). "Evidence of testicular activity in early infancy". J. Clin. Endocrinol. Metab.37 (1): 148–51. PMID4715291. doi:10.1210/jcem-37-1-148.
Corbier P, Edwards DA, Roffi J (1992). "The neonatal testosterone surge: a comparative study". Arch Int Physiol Biochim Biophys100 (2): 127–31. PMID1379488. doi:10.3109/13813459209035274.
Dakin CL, Wilson CA, Kalló I, Coen CW, Davies DC (2008). "Neonatal stimulation of 5-HT(2) receptors reduces androgen receptor expression in the rat anteroventral periventricular nucleus and sexually dimorphic preoptic area". Eur. J. Neurosci.27 (9): 2473–80. PMID18445234. doi:10.1111/j.1460-9568.2008.06216.x.
Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R (1996). "The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men". N. Engl. J. Med.335 (1): 1–7. PMID8637535. doi:10.1056/NEJM199607043350101.
Ajayi AA, Halushka PV (2005). "Castration reduces platelet thromboxane A2 receptor density and aggregability". QJM98 (5): 349–56. PMID15820970. doi:10.1093/qjmed/hci054.
Morgentaler A, Schulman C (2009). "Testosterone and prostate safety". Front Horm Res37: 197–203. PMID19011298. doi:10.1159/000176054.
Rhoden, E.L., M.A. Averbeck, and P.E. Teloken (2008). "Androgen replacement in men undergoing treatment for prostate cancer". J Sex Med5 (9): 2202–8. PMID18638000. doi:10.1111/j.1743-6109.2008.00925.x.
Morgentaler, A. and A.M. Traish (2009). "Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth". Eur Urol55 (2): 310–20. PMID18838208. doi:10.1016/j.eururo.2008.09.024.
Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ, Montori VM (2007). "Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials". Mayo Clin. Proc.82 (1): 29–39. PMID17285783. doi:10.4065/82.1.29.
Jones TH, Saad F (2009). "The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process". Atherosclerosis207 (2): 318–27. PMID19464009. doi:10.1016/j.atherosclerosis.2009.04.016.
Apicella CL, Dreber A, Campbell B, Gray PB, Hoffman M, Little AC (2008). "Testosterone and financial risk preferences". Evolution and Human Behavior29 (6): 384–390. doi:10.1016/j.evolhumbehav.2008.07.001.
Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004). "Low free testosterone is an independent risk factor for Alzheimer's disease". Exp. Gerontol.39 (11-12): 1633–9. PMID15582279. doi:10.1016/j.exger.2004.06.019.
Moffat SD, Hampson E (1996). "A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference". Psychoneuroendocrinology21 (3): 323–37. PMID8817730. doi:10.1016/0306-4530(95)00051-8.
Pike CJ, Rosario ER, Nguyen TV (2006). "Androgens, aging, and Alzheimer's disease". Endocrine29 (2): 233–41. PMID16785599. doi:10.1385/ENDO:29:2:233.
Rosario ER, Chang L, Stanczyk FZ, Pike CJ (2004). "Age-related testosterone depletion and the development of Alzheimer disease". JAMA292 (12): 1431–2. PMID15383512. doi:10.1001/jama.292.12.1431-b.
Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB (2007). "A population-level decline in serum testosterone levels in American men". J. Clin. Endocrinol. Metab.92 (1): 196–202. PMID17062768. doi:10.1210/jc.2006-1375.
Bhasin S (2007). "Secular decline in male reproductive function: Is manliness threatened?". J. Clin. Endocrinol. Metab.92 (1): 44–5. PMID17209224. doi:10.1210/jc.2006-2438.
Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J (2008). "Testosterone for low libido in postmenopausal women not taking estrogen". N. Engl. J. Med.359 (19): 2005–17. PMID18987368. doi:10.1056/NEJMoa0707302.
"Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility". Lancet336 (8721): 955–9. 1990. PMID1977002. doi:10.1016/0140-6736(90)92416-F.
Traish AM, Saad F, Guay A (2009). "The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance". J. Androl.30 (1): 23–32. PMID18772488. doi:10.2164/jandrol.108.005751.
Kicman AT, Cowan DA (2009). "Subject-based profiling for the detection of testosterone administration in sport". Drug Test Anal1 (1): 22–4. PMID20355155. doi:10.1002/dta.14.
Bratoeff E, Cabeza M, Ramirez E, Heuze Y, Flores E (2005). "Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors". Curr. Med. Chem.12 (8): 927–43. PMID15853706. doi:10.2174/0929867053507306.
Engel JB, Schally AV (2007). "Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone". Nat Clin Pract Endocrinol Metab3 (2): 157–67. PMID17237842. doi:10.1038/ncpendmet0399.
David KG., Dingemanse E, Freud J. Laqueur E (1935). "Über krystallinisches mannliches Hormon aus Hoden (Testosteron) wirksamer als aus harn oder aus Cholesterin bereitetes Androsteron" [On crystalline male hormone from testicles (testosterone) effective as from urine or from cholesterol]. Hoppe Seylers Z Physiol Chem(en German)233 (5–6): 281. doi:10.1515/bchm2.1935.233.5-6.281.
Butenandt A, Hanisch G (1935). "Umwandlung des Dehydroandrosterons in Androstendiol und Testosterone; ein Weg zur Darstellung des Testosterons aus Cholestrin" [About Testosterone. Conversion of Dehydro-androsterons into androstendiol and testosterone; a way for the structure assignment of testosterone from cholestrol]. Hoppe Seylers Z Physiol Chem(en German)237 (2): 89. doi:10.1515/bchm2.1935.237.1-3.89.
Ruzicka L, Wettstein A (1935). "Uber die kristallinische Herstellung des Testikelhormons, Testosteron (Androsten-3-ol-17-ol) [The crystalline production of the testicle hormone, testosterone (Androsten-3-ol-17-ol]". Helvetica Chimica Acta(en German)18: 1264–1275. doi:10.1002/hlca.193501801176.
Cox RM, John-Alder HB (2005). "Testosterone has opposite effects on male growth in lizards (Sceloporus spp.) with opposite patterns of sexual size dimorphism". J. Exp. Biol.208 (Pt 24): 4679–87. PMID16326949. doi:10.1242/jeb.01948.
Tuck SP, Francis RM (2009). "Testosterone, bone and osteoporosis". Front Horm Res37: 123–32. PMID19011293. doi:10.1159/000176049.
Waterman MR, Keeney DS (1992). "Genes involved in androgen biosynthesis and the male phenotype". Horm. Res.38 (5-6): 217–21. PMID1307739. doi:10.1159/000182546.
Swerdloff RS, Wang C, Bhasin S (1992). "Developments in the control of testicular function". Baillieres Clin. Endocrinol. Metab.6 (2): 451–83. PMID1377467. doi:10.1016/S0950-351X(05)80158-2.
Mehta PH, Josephs RA (2006). "Testosterone change after losing predicts the decision to compete again". Horm Behav50 (5): 684–92. PMID16928375. doi:10.1016/j.yhbeh.2006.07.001.
Schultheiss OC, Campbell KL, McClelland DC (1999). "Implicit power motivation moderates men's testosterone responses to imagined and real dominance success". Horm Behav36 (3): 234–41. PMID10603287. doi:10.1006/hbeh.1999.1542.
Liu PY, Pincus SM, Takahashi PY, Roebuck PD, Iranmanesh A, Keenan DM, Veldhuis JD (2006). "Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade". Am. J. Physiol. Endocrinol. Metab.290 (1): E34–E41. PMID16339924. doi:10.1152/ajpendo.00227.2005.
Hulmi JJ, Ahtiainen JP, Selänne H, Volek JS, Häkkinen K, Kovanen V, Mero AA (2008). "Androgen receptors and testosterone in men--effects of protein ingestion, resistance exercise and fiber type". J. Steroid Biochem. Mol. Biol.110 (1-2): 130–7. PMID18455389. doi:10.1016/j.jsbmb.2008.03.030.
Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ (1996). "Zinc status and serum testosterone levels of healthy adults". Nutrition12 (5): 344–8. PMID8875519. doi:10.1016/S0899-9007(96)80058-X.
Koehler K, Parr MK, Geyer H, Mester J, Schänzer W (2009). "Serum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement". Eur J Clin Nutr63 (1): 65–70. PMID17882141. doi:10.1038/sj.ejcn.1602899.
Josephs RA, Guinn JS, Harper ML, Askari F (2001). "Liquorice consumption and salivary testosterone concentrations". Lancet358 (9293): 1613–4. PMID11716893. doi:10.1016/S0140-6736(01)06664-8.
Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş N (2007). "Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism". Phytother Res21 (5): 444–7. PMID17310494. doi:10.1002/ptr.2074.
Kumar V, Kural MR, Pereira BM, Roy P (2008). "Spearmint induced hypothalamic oxidative stress and testicular anti-androgenicity in male rats - altered levels of gene expression, enzymes and hormones". Food Chem. Toxicol.46 (12): 3563–70. PMID18804513. doi:10.1016/j.fct.2008.08.027.
Grant P (2010). "Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial". Phytother Res24 (2): 186–8. PMID19585478. doi:10.1002/ptr.2900.
Meinhardt U, Mullis PE (2002). "The essential role of the aromatase/p450arom". Semin. Reprod. Med.20 (3): 277–84. PMID12428207. doi:10.1055/s-2002-35374.
Breiner M, Romalo G, Schweikert HU (1986). "Inhibition of androgen receptor binding by natural and synthetic steroids in cultured human genital skin fibroblasts". Klin. Wochenschr.64 (16): 732–7. PMID3762019. doi:10.1007/BF01734339.
Swaab DF, Garcia-Falgueras A (2009). "Sexual differentiation of the human brain in relation to gender identity and sexual orientation". Funct. Neurol.24 (1): 17–28. PMID19403051.
Forest MG, Cathiard AM, Bertrand JA (1973). "Evidence of testicular activity in early infancy". J. Clin. Endocrinol. Metab.37 (1): 148–51. PMID4715291. doi:10.1210/jcem-37-1-148.
Corbier P, Edwards DA, Roffi J (1992). "The neonatal testosterone surge: a comparative study". Arch Int Physiol Biochim Biophys100 (2): 127–31. PMID1379488. doi:10.3109/13813459209035274.
Dakin CL, Wilson CA, Kalló I, Coen CW, Davies DC (2008). "Neonatal stimulation of 5-HT(2) receptors reduces androgen receptor expression in the rat anteroventral periventricular nucleus and sexually dimorphic preoptic area". Eur. J. Neurosci.27 (9): 2473–80. PMID18445234. doi:10.1111/j.1460-9568.2008.06216.x.
Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R (1996). "The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men". N. Engl. J. Med.335 (1): 1–7. PMID8637535. doi:10.1056/NEJM199607043350101.
Ajayi AA, Halushka PV (2005). "Castration reduces platelet thromboxane A2 receptor density and aggregability". QJM98 (5): 349–56. PMID15820970. doi:10.1093/qjmed/hci054.
Ajayi AA, Mathur R, Halushka PV (1995). "Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses". Circulation91 (11): 2742–7. PMID7758179.
Morgentaler A, Schulman C (2009). "Testosterone and prostate safety". Front Horm Res37: 197–203. PMID19011298. doi:10.1159/000176054.
Rhoden, E.L., M.A. Averbeck, and P.E. Teloken (2008). "Androgen replacement in men undergoing treatment for prostate cancer". J Sex Med5 (9): 2202–8. PMID18638000. doi:10.1111/j.1743-6109.2008.00925.x.
Morgentaler, A. and A.M. Traish (2009). "Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth". Eur Urol55 (2): 310–20. PMID18838208. doi:10.1016/j.eururo.2008.09.024.
Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ, Montori VM (2007). "Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials". Mayo Clin. Proc.82 (1): 29–39. PMID17285783. doi:10.4065/82.1.29.
Jones TH, Saad F (2009). "The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process". Atherosclerosis207 (2): 318–27. PMID19464009. doi:10.1016/j.atherosclerosis.2009.04.016.
Marner L, Nyengaard JR, Tang Y, Pakkenberg B. (2003). Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol. 462(2):144-52. [1]PMID 12794739
Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004). "Low free testosterone is an independent risk factor for Alzheimer's disease". Exp. Gerontol.39 (11-12): 1633–9. PMID15582279. doi:10.1016/j.exger.2004.06.019.
Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM (2004). "Free testosterone and risk for Alzheimer disease in older men". Neurology62 (2): 188–93. PMID14745052.
Moffat SD, Hampson E (1996). "A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference". Psychoneuroendocrinology21 (3): 323–37. PMID8817730. doi:10.1016/0306-4530(95)00051-8.
Pike CJ, Rosario ER, Nguyen TV (2006). "Androgens, aging, and Alzheimer's disease". Endocrine29 (2): 233–41. PMID16785599. doi:10.1385/ENDO:29:2:233.
Rosario ER, Chang L, Stanczyk FZ, Pike CJ (2004). "Age-related testosterone depletion and the development of Alzheimer disease". JAMA292 (12): 1431–2. PMID15383512. doi:10.1001/jama.292.12.1431-b.
Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB (2007). "A population-level decline in serum testosterone levels in American men". J. Clin. Endocrinol. Metab.92 (1): 196–202. PMID17062768. doi:10.1210/jc.2006-1375.
Bhasin S (2007). "Secular decline in male reproductive function: Is manliness threatened?". J. Clin. Endocrinol. Metab.92 (1): 44–5. PMID17209224. doi:10.1210/jc.2006-2438.
Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J (2008). "Testosterone for low libido in postmenopausal women not taking estrogen". N. Engl. J. Med.359 (19): 2005–17. PMID18987368. doi:10.1056/NEJMoa0707302.
"Testosterone replacement therapy for male aging: ASA position statement". J. Androl.27 (2): 133–4. 2006. PMID16474019.
"Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility". Lancet336 (8721): 955–9. 1990. PMID1977002. doi:10.1016/0140-6736(90)92416-F.
Traish AM, Saad F, Guay A (2009). "The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance". J. Androl.30 (1): 23–32. PMID18772488. doi:10.2164/jandrol.108.005751.
Kicman AT, Cowan DA (2009). "Subject-based profiling for the detection of testosterone administration in sport". Drug Test Anal1 (1): 22–4. PMID20355155. doi:10.1002/dta.14.
Bratoeff E, Cabeza M, Ramirez E, Heuze Y, Flores E (2005). "Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors". Curr. Med. Chem.12 (8): 927–43. PMID15853706. doi:10.2174/0929867053507306.
Engel JB, Schally AV (2007). "Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone". Nat Clin Pract Endocrinol Metab3 (2): 157–67. PMID17237842. doi:10.1038/ncpendmet0399.
"Anabolic Steroid Control Act"(PDF). United States Sentencing Commission. 1990. Arquivado dende o orixinal(PDF) o 07 de maio de 2006. Consultado o 25 de xaneiro de 2012.
"Anabolic Steroid Control Act"(PDF). United States Sentencing Commission. 1990. Arquivado dende o orixinal(PDF) o 07 de maio de 2006. Consultado o 25 de xaneiro de 2012.